Item 2. Unregistered Sales of Equity Securities
Item 2. Unregistered Sales of Equity
Securities and Use of Proceeds.
During the three-months ended October 31, 2021,
we issued an aggregate of 334 unregistered shares of common stock to one of our directors pursuant to his DLA. The non-cash expense for
this share issuance totaled $1,065.
During the three-months ended October 31, 2021,
we issued an aggregate of 334 stock options to one of our directors pursuant to his DLA. The non-cash expense for stock option totaled
$798.
During the three-months ended October 31, 2021,
we issued an aggregate of 334 unregistered shares of common stock in respect of his services as the Chairman of the Company’s Medical
and Scientific Advisory Board. The non-cash expense for these share issuances totaled $1,059.
All such securities were issued without registration
under the Securities Act of 1933, as amended, in reliance upon the exemption afforded by Section 4(a)(2) of that Act.
Item 3. Defaults Upon Senior Securities.
None.
Item 4. Mine Safety Disclosure.
Not applicable.
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.